Tracked deals
8
8 tracked deals across 2020-2024.
Operating Company
Manufacturing
Actylis
Port Washington, New York, United States
Formerly known as Aceto, Aceto Corporation, Aceto U.S., LLC
Actylis is an integrated specialty ingredients manufacturing and sourcing platform providing GMP and non-GMP specialty ingredients and related materials for life sciences and advanced-technology end markets.
- Focus Areas
- Specialty ingredients, GMP manufacturing, Sourcing and R&D for specialty ingredients
- Website
- actylis.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
7 buyout · 1 addon
Actylis Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
October 7, 2024
- Buyer
- Actylis
- Target
- Pharm-Rx
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Type
- Buyout
Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.
-
September 26, 2022
- Buyer
- Actylis, New Mountain Capital
- Target
- Aceto, A&C, A&C Bio Buffer, Biotron Laboratories, Cascade Chemistry, Finar, Inter-Actifs, IsleChem, Pharma Waldhof, Syntor Fine Chemicals, Talus
- Industry
- Manufacturing
- Location
- New York, United States
- Type
- Addon
New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.
-
- Buyer
- Aceto
- Target
- Biotron Laboratories, Talus Mineral Company
- Industry
- Manufacturing
- Location
- Utah, United States
- Type
- Buyout
Aceto has acquired Biotron Laboratories and Talus Mineral Company (collectively "Biotron"), two Utah-based manufacturers of specialty minerals and mineral chelates for the nutritional supplements industry. The acquisition expands Aceto's nutraceuticals capabilities and life-science manufacturing footprint; Biotron operates two manufacturing facilities in Centerville and Ogden, Utah, and is known for proprietary amino-acid based chelation technology. Financial terms were not disclosed.
-
January 26, 2022
- Buyer
- Aceto
- Target
- A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem, Syntor Fine Chemicals
- Industry
- Pharmaceuticals
- Location
- United States
- Type
- Buyout
Aceto has consolidated and integrated six recent manufacturing-related acquisitions — A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals — to create a hybrid manufacturing/distribution model that strengthens its GMP manufacturing, R&D and supply-chain capabilities across pharmaceuticals, biopharma, vaccines, nutraceuticals, agri-science and specialty chemicals. The acquisitions expand Aceto’s global manufacturing footprint (North America, Europe and Asia), broaden its portfolio of excipients, APIs and process solutions, and improve supply-chain resilience for customers.
-
October 12, 2021
- Buyer
- Aceto
- Target
- A&C Bio Buffer Ltd
- Seller
- A&C Group
- Industry
- Pharmaceuticals
- Location
- Ireland
- Type
- Buyout
Aceto has acquired A&C Bio Buffer Ltd, a GMP manufacturer of custom buffers and chemical blends based in Limerick, Ireland. The acquisition expands Aceto’s GMP product lines and European manufacturing footprint, complementing its earlier purchase of A&C and strengthening capabilities for biopharmaceutical and vaccine manufacturing.
-
June 2, 2021
- Buyer
- Aceto
- Target
- Cascade Chemistry
- Industry
- Pharmaceuticals
- Location
- Oregon, United States
- Type
- Buyout
Aceto, a global provider of specialty materials for life sciences and advanced technology end markets, acquired Eugene, Oregon-based Cascade Chemistry, a CDMO specializing in active pharmaceutical ingredients (APIs) and advanced intermediates. The acquisition strengthens Aceto's U.S. cGMP custom manufacturing capabilities and expands North American API manufacturing capacity; Cascade Chemistry recently announced a facility expansion that will triple its clinical-stage API capacity.
-
April 15, 2021
- Buyer
- Aceto
- Target
- A&C
- Industry
- Pharmaceuticals
- Location
- Quebec, Canada
- Type
- Buyout
Aceto has acquired A&C, a global GMP manufacturer of specialty excipients, buffers and process solutions, expanding Aceto's self-manufacturing and custom product capabilities for the vaccine, cell culture and biopharmaceutical markets. The deal adds GMP manufacturing, packaging and ingredient offerings and expands Aceto's North American and European footprint; financial terms were not disclosed.
-
December 21, 2020
- Buyer
- Aceto U.S., LLC
- Target
- IsleChem, LLC
- Industry
- Manufacturing
- Location
- New York, United States
- Type
- Buyout
Aceto U.S., LLC has acquired IsleChem, a Grand Island, New York-based chemical manufacturer and contract R&D provider. The acquisition adds U.S. manufacturing, analytical and R&D capabilities to Aceto’s global specialty-chemicals sourcing and distribution platform and supports expansion of IsleChem’s facility and workforce.
Related Acquisition Pages
Pharmaceuticals Buyers & Acquisitions
5 tracked deals by Actylis.
Manufacturing Buyers & Acquisitions
3 tracked deals by Actylis.
Acquisitions in New York
2 tracked deals by Actylis.
Acquisitions in New Jersey
1 tracked deal by Actylis.
Acquisitions in Oregon
1 tracked deal by Actylis.
Acquisitions in Utah
1 tracked deal by Actylis.
Selling a company? Get in front of buyers like Actylis
Turn tracked acquisition activity into an outreach-ready buyer list.